Coordinated facilities requirements for FY22 task order - b
Ended Awarded Last action
- Contract number
- 75N91022F00008
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,197,453
Award facts
- Contract value 100% obligated
- $7,197,453.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$170,245 | |
| Terminate for Convenience | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $37,894 | |
| Funding Only Action | $21,551 | |
| Change Order | $68,603 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $1,111,462 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $6,128,188 |
Show all 16
About this award
Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. and Federally Funded Research and Development Center (FFRDC) contractor, was awarded a delivery order valued at $7.2 million by the National Cancer Institute (NCI) on April 26, 2022, for Coordinated Facilities Requirements in Fiscal Year 2022. The contract, which operates under a cost-plus-fixed-fee pricing structure with no set-aside designation, is scheduled for completion by October 24, 2025 and will be performed at the contractor's facility in Frederick, Maryland. As an FFRDC provider, Leidos Biomedical Research Inc. delivers comprehensive biomedical research and facilities support services to the NCI and broader National Institutes of Health portfolio, leveraging the Frederick National Laboratory for Cancer Research infrastructure.
This delivery order supports the National Cancer Institute's research and operational infrastructure needs through Leidos' extensive capabilities in medical research support, clinical trials administration, facility management, and advanced scientific services. Leidos Biomedical Research Inc. has established a track record of managing similar cost-plus-fixed-fee delivery orders for NCI and related federal health agencies, with contract work spanning cancer research, gene therapy development, infectious disease research, clinical trial support, and specialized laboratory services. The award reflects the contractor's competitive positioning within the federal biomedical research community and its critical role in supporting the government's cancer research mission.
Quick answers
Who was awarded contract 75N91022F00008?
75N91022F00008 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on April 26, 2022.
How much is contract 75N91022F00008 worth?
The government has obligated $7,197,453 on 75N91022F00008.
Is contract 75N91022F00008 an order under another contract?
Yes. 75N91022F00008 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91022F00008 competed?
The extent of competition for 75N91022F00008 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award